@article{CCO24392,
author = {Siddharth Turkar and Anant Ramaswamy and Vikas Ostwal},
title = {A step ahead on CTHRC1, and not just reinventing the wheel!},
journal = {Chinese Clinical Oncology},
volume = {8},
number = {Suppl 1},
year = {2019},
keywords = {},
abstract = {The association of CTHRC1 with tumor progression is demonstrated in various human cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, GIST and colorectal cancer (1-3). In a meta-analysis done by Wang et al., the results revealed correlation of CTHRC1 expression with TNM stage in gastric cancer, breast cancer, and hepatocellular carcinoma (4). It indicated CTHRC1’s role as a biomarker for prognosis of cancer patients by showing that patients with higher CTHRC1 expression had decreased overall survival (OS) and disease-free survival (DFS) which was statistically significant (4).},
issn = {2304-3873}, url = {https://cco.amegroups.org/article/view/24392}
}